DNLIDENALI THERAPEUTICS INC
CUSIP 24823R105 · common stock
3 tracked investors held DENALI THERAPEUTICS INC (DNLI) at the end of Q3 2026, worth $170.9M in total. The largest holder was Julian Baker, with 0.4% of its portfolio.
Holders · Q3 2026
3
New holders
0
Value held
$170.9M
Quarter-end price (est.)
$20.67
Investors holding DNLI · Q3 2026
| Investor | Weight | Shares | Value | Change |
|---|---|---|---|---|
| Julian Baker Baker Bros. Advisors LP | 0.37% | 3,734,336 | $77.2M | HOLD |
| Ken Fisher Fisher Asset Management, LLC | 0.01% | 2,460,545 | $50.9M | ADD+1.9% |
| Adar1 Capital Management ADAR1 Capital Management, LLC | 1.82% | 2,072,050 | $42.8M | ADD+101.3% |